Histology services provider and specialist in tissue analysis, Immunohistochemistry and In Situ Hybridization since 2005.
Slide of the week
PD-L1 labeling on human pancreatic carcinoma
Make your quote online
Histalim is a service provider company in histology, immunohistochemistry (IHC), in situ hybridization (ISH), and image analysis. Our laboratory located in Montpellier was founded in 2005. This positioning shows our willingness to meet the increasing demand to design, develop, and validate protocols based on standard and/or innovative techniques.
Our specialized services take part in research and development projects for pharmaceutic products, medical devices, and diagnostic tools… and in other domains like dermo-cosmetic, ecotoxicity, food industry… We are particularly engaged in the development of new therapies in the domains of oncology and chronic diseases i.e. therapeutic antibody, and new generation diagnostic tools i.e. circulating biomarkers. Histalim positions its strategic growth specifically in the development of therapeutic antibodies issues.
Our activities are conformed to Good Laboratory Practices (GLP) and our laboratory is authorized to perform studies with human tissue samples. Histalim can also offer to perform in-house research and development projects. This particularity allows us to provide some customized services to our customers, with innovative technologies. Therefore we can provide a large range of expert services like Tissue Cross Reactivity (TCR) studies, Tissue MicroArray (TMA), and Fluorescent ISH (FISH)…
HISTALIM is delighted by INNATE PHARMA’s encouraging results in the framework of its clinical trial testing IPH4102 on the cutaneous T-cell lymphomas.28 October 2016Read more
INNATE PHARMA search results are presented at Columbia University in New-York, USA, this Friday, October 28, 2016. HISTALIM’s teams...
- 3 October 2016Read more
Histalim looks forward to meet you at Maison de la Chimie of Paris the 3rd and 4th of October...